XERS Xeris Biopharma Holdings, Inc.: institutional ownership and insider trading
251 funds reported holding $976M of Xeris Biopharma Holdings, Inc. in their latest 13F filings; in Q2 2026 funds net bought $111M, with 38 new positions and 27 funds selling out; over the last 12 months insiders bought $0 and sold $5.35M on the open market; over its last four quarters it reported revenue of $335M and net income of −$17.2M.
XERS revenue and earnings
- Quarter ended Jun 30, 2026: revenue $92.1M, net income −$31.1M, EPS -0.18
- Quarter ended Mar 31, 2026: revenue $83.1M, net income $2.23M, EPS 0.01
- Quarter ended Dec 31, 2025: revenue $85.8M, net income $11.1M, EPS 0.07
- Quarter ended Sep 30, 2025: revenue $74.4M, net income $621K, EPS 0.00
Famous investors holding XERS
- D. E. Shaw (D. E. Shaw & Co.): $61.8M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $14.9M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $6.12M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $1.04M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $533K, 0.0% of the portfolio
Largest institutional holders of XERS
- BlackRock, Inc. (BLK) — $115M
- VANGUARD GROUP INC — $87.8M
- D. E. Shaw & Co., Inc. — $61.8M
- VANGUARD CAPITAL MANAGEMENT LLC — $58.1M
- STATE STREET CORP (STT, STT-PG) — $38.2M
- GEODE CAPITAL MANAGEMENT, LLC — $37.4M
- Nuveen, LLC — $34.7M
- Rosalind Advisors, Inc. — $23.0M
- Qube Research & Technologies Ltd — $22.9M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $20.8M
Recent XERS insider trades
- Oct 1, 2026: Hecht Beth sold 16,666 shares ($157K)
- Oct 1, 2026: McCulloch Kevin sold 15,000 shares ($141K)
- Oct 1, 2026: Pieper Steven sold 5,000 shares ($47.0K)
- Sep 28, 2026: McCulloch Kevin sold 25,000 shares ($250K)
5%+ owners
- Vanguard Capital Management: 5.0% (Schedule 13G, filed Jul 31, 2026)
Who owns the most XERS stock?
The largest institutional holders of Xeris Biopharma Holdings, Inc. in the latest 13F filings are BlackRock, Inc. (BLK) ($115M), VANGUARD GROUP INC ($87.8M), D. E. Shaw & Co., Inc. ($61.8M).
Are insiders buying or selling XERS?
Over the last 12 months insiders bought $0 and sold $5.35M of Xeris Biopharma Holdings, Inc. stock on the open market (SEC Form 4).
Which famous investors own XERS?
D. E. Shaw, Two Sigma, Ken Griffin, Izzy Englander, Renaissance Technologies.
What was XERS's revenue last quarter?
Xeris Biopharma Holdings, Inc. reported revenue of $92.1M for the quarter ended June 30, 2026, with net income of −$31.1M.
Which ETFs hold XERS?
22 ETFs and mutual funds hold it among their top 100 positions, including FYC, XPH, IWC, RVPHX.